Outspoken pharma critics are posting damaging comments on Google Sidewiki now, and while AstraZeneca has taken the first step in countering this, pharma companies at large quickly need to be developing and enforcing a policy on this. The threat is real, it is happening now, and without being addressed, it quite realistically could escalate into a larger issue for the industry – small issues like this have a tendency to flare up once adopted by a vocal online community and Sidewiki could well be the spark that starts the fire.
Posts Tagged ‘AstraZeneca’
Sidewiki no longer a side-issue for pharma
Thursday, November 26th, 2009Pharma ‘brand’ websites: A thing of the past?
Friday, October 16th, 2009Not too long ago, digital pharma guru and blogger Jonathan Richman wrote an inspiring post entitled ‘Ten Digital Marketing Ideas Pharma Companies Will Never Try (But Should)’. Number two in his list was to ‘get rid of your brand website’, based on the fact they are not widely visited by patients and provide little benefit, compared to syndicating content to third party sites. While this vision is not all there (yet), it seems to be happening step by step…
